Strengthening Research Integrity Oversight and Ethical Review of Critical HIV Research in China
加强中国艾滋病毒关键研究的研究诚信监督和伦理审查
基本信息
- 批准号:9766700
- 负责人:
- 金额:$ 9.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-19 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAreaBiomedical ResearchCase StudyCenters for Disease Control and Prevention (U.S.)ChinaChinese PeopleCountryDevelopmentE-learningEducational process of instructingEducational workshopEnsureEnvironmentEpidemicEthical ReviewEthicsEventFraudFundingFutureGoalsGrowthHIVHumanIndividualInfrastructureInstitutionInstitutional Review BoardsInternationalJournalsLeadLearningLearning ModuleLiteratureManuscriptsMedicalMentorsMentorshipMissionModelingPaperPeer ReviewPlagiarismPoliciesPreventionProcessPublicationsRecommendationRecording of previous eventsReportingResearchResearch EthicsResearch MisconductResearch PersonnelResearch ProposalsResearch TrainingResourcesScienceScientistSelf-ExaminationStructureStudentsSuggestionTrainingTraining ActivityTraining ProgramsUniversitiesUpdateWritingapprenticeshipbasecareerexpectationexperiencehuman subject protectionimprovedinternational centerlow and middle-income countriesmeetingsmemberneglectnext generationoutreachpreventprogramsresponsible research conduct
项目摘要
PROJECT SUMMARY/ABSTRACT
Scientific research capacity has grown enormously in China in recent years, and China has since become the
largest contributor to the literature. However, recent discoveries of research misconduct, which have had a
negative impact on Chinese scientists and their US collaborators, related to inadequate ethical review, neglect
for human subjects protections, and publication fraud have highlighted China's under-developed research ethics
capacity and infrastructure. China must act now to instill the principles of responsible conduct of research (RCR)
in its next generation of scientists. The National Center for AIDS/STD Control and Prevention (NCAIDS) at the
Chinese Center for Disease Control and Prevention (China CDC) has a long history of conducting critical HIV
research in priority areas and is dedicated to continuing this mission into the future. Moreover, it is
committed to
leading the way for China in elevating research integrity to the international standard, not only by serving as an
example, but also by helping other domestic institutions improve in this area.
The capacity building strategies
proposed herein are crucial next steps toward achieving this broader, long-term goal, and are also in line with
the goal of the Fogarty International Center (FIC) HIV Research Training Program “to strengthen the human
capacity to contribute to the ability of institutions in low- and middle-income countries (LMIC) to conduct HIV-
related research on the evolving HIV-related epidemics in their country and to compete independently for
research funding.” Building on existing institutional structures and resources at NCAIDS, China CDC, 2 aims are
proposed.
The proposal's first aim is to strengthen research integrity oversight of manuscripts at NCAIDS and at
Anhui Medical University (AMU) and Kunming Medical University (KMU).
To achieve this aim, 3 activities are
proposed: (1) publication ethics workshop, where researchers at all levels will receive training on issues including
plagiarism (how to avoid, detect, and remedy it), acceptable citation practices, and institutional and international
expectations for ethical publication, (2) publication ethics case study e-learning modules will be developed and
continually be updated to cover new cases and/or new forms of ethics violations, and (3) internal pre-submission
manuscript review, a new process that will be developed and launched for the purpose of evaluating manuscripts
The
proposal's second aim is to strengthen ethical review of research proposals for the protection of human subjects
at NCAIDS and AMU and KMU. To accomplish this aim, an additional 2 activities are proposed: (4) institutional
review board (IRB) apprenticeships, whereby IRB members from AMU and KMU spend 3 days at NCAIDS
working directly with NCAIDS IRB members and (5) IRB workshops, where NCAIDS AMU and KMU IRB
members attend each other's IRB meetings and then put on a workshop-style event where critical review and
for science quality, writing quality, and integrity of reporting, ensuring compliance to ethical standards.
suggestions on areas of potential improvement are provided.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ZUNYOU WU其他文献
ZUNYOU WU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ZUNYOU WU', 18)}}的其他基金
Strengthening Research Integrity Oversight and Ethical Review of Critical HIV Research in China
加强中国艾滋病毒关键研究的研究诚信监督和伦理审查
- 批准号:
10018125 - 财政年份:2019
- 资助金额:
$ 9.94万 - 项目类别:
Technical Collaboration with the People's Republis of China on Innovative Approac
与中华人民共和国就创新方法进行技术合作
- 批准号:
8848607 - 财政年份:2014
- 资助金额:
$ 9.94万 - 项目类别:
PREVENTION OF SECONDARY TRANSMISSION AMONG MOST-AT-RISK POPULATIONS
预防高危人群的二次传播
- 批准号:
7645997 - 财政年份:2008
- 资助金额:
$ 9.94万 - 项目类别:
PREVENTION OF SECONDARY TRANSMISSION AMONG MOST-AT-RISK POPULATIONS
预防高危人群的二次传播
- 批准号:
8309917 - 财政年份:2008
- 资助金额:
$ 9.94万 - 项目类别:
PREVENTION OF SECONDARY TRANSMISSION AMONG MOST-AT-RISK POPULATIONS
预防高危人群的二次传播
- 批准号:
8138630 - 财政年份:2008
- 资助金额:
$ 9.94万 - 项目类别:
PREVENTION OF SECONDARY TRANSMISSION AMONG MOST-AT-RISK POPULATIONS
预防高危人群的二次传播
- 批准号:
8334361 - 财政年份:2008
- 资助金额:
$ 9.94万 - 项目类别:
PREVENTION OF SECONDARY TRANSMISSION AMONG MOST-AT-RISK POPULATIONS
预防高危人群的二次传播
- 批准号:
7919345 - 财政年份:2008
- 资助金额:
$ 9.94万 - 项目类别:
PREVENTION OF SECONDARY TRANSMISSION AMONG MOST-AT-RISK POPULATIONS
预防高危人群的二次传播
- 批准号:
8530746 - 财政年份:2008
- 资助金额:
$ 9.94万 - 项目类别:
PREVENTION OF SECONDARY TRANSMISSION AMONG MOST-AT-RISK POPULATIONS
预防高危人群的二次传播
- 批准号:
7690376 - 财政年份:2008
- 资助金额:
$ 9.94万 - 项目类别:
China Multidisciplinary AIDS Prevention Training Program
中国艾滋病多学科预防培训项目
- 批准号:
6780164 - 财政年份:2004
- 资助金额:
$ 9.94万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 9.94万 - 项目类别:
Research Grant














{{item.name}}会员




